Pancreatic Cancer | Tumor

CURE’s pancreatic cancer page features the latest cancer news and updates on pancreatic cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in pancreatic cancer.

A Trailblazer in Oncology Nursing and Research

May 21st 2025, 9:00pm

Article

Gayle S. Jameson, M.S.N, ACNP-BC, AOCN, is a trailblazer whose expertise and compassion have made a profound impact on oncology care.

2025 Quarter 1 – COA Patient Advocacy Network News Bulletin.

May 16th 2025, 8:28pm

Article

Enclosed is the 2025 Quarter 1 – COA Patient Advocacy Network News Bulletin.

Eraglusib Combo Improves Survival in Metastatic Pancreatic Cancer

May 9th 2025, 4:45pm

Article

Eraglusib with gemcitabine and nab-paclitaxel achieved statistical significance in the first-line treatment of metastatic pancreatic ductal adenocarcinoma.

Honoring a Healer: Personal Care With National Impact

May 7th 2025, 9:00pm

Article

This is a joint nomination by Camille Moses and Dr. Estelamari Rodriguez.

CM24 Combo With Biomarker Targeting Improves Survival in Pancreatic Cancer

April 30th 2025, 4:01pm

Article

CM24 plus Opdivo and chemo improved survival in pancreatic cancer with CEACAM1 biomarkers, supporting a biomarker-driven phase 2b study.

New Jersey Patients Receiving First-of-Its-Kind Catheter Based Pancreatic Cancer Treatment

April 17th 2025, 6:13pm

Article

Experts at Hackensack Meridian Jersey Shore University Medical Center have successfully treated their first patients using the TAMP™ therapy platform.

U.S. Centers Seek Namodenoson for Pancreatic Cancer Compassionate Use

April 17th 2025, 4:00pm

Article

U.S. medical centers are seeking FDA authorization for the compassionate use — or expanded access — of Namodenoson for patients with pancreatic cancer.

First Patient Dosed With KSQ-004EX In Solid Tumor Clinical Trial

April 12th 2025, 2:00pm

Article

KSQ-004EX is being evaluated in solid tumors including melanoma, non-small cell lung, head and neck, colorectal, pancreatic and cervical cancer.

FDA Grants Compassionate Use Treatment to Namodenoson in Pancreatic Cancer

March 19th 2025, 3:00pm

Article

The FDA has granted approval to an act of compassionate use treatment with the anti-cancer drug Namodenoson for a patient with pancreatic cancer.

FDA Grants Orphan Drug Designation to PEP-010 in Pancreatic Cancer

March 17th 2025, 3:00pm

Article

The FDA has granted orphan drug designation to PEP-010 for pancreatic cancer, advancing its development as a potential novel treatment for the disease.